Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 7 | 2025 | 441 | 2.580 |
Why?
|
| Fornix, Brain | 5 | 2025 | 23 | 1.670 |
Why?
|
| Rett Syndrome | 7 | 2023 | 229 | 1.590 |
Why?
|
| Fear | 10 | 2021 | 190 | 1.240 |
Why?
|
| Hippocampus | 8 | 2025 | 793 | 1.150 |
Why?
|
| Memory | 7 | 2025 | 306 | 1.010 |
Why?
|
| Dentate Gyrus | 3 | 2021 | 37 | 0.870 |
Why?
|
| Neural Inhibition | 3 | 2021 | 108 | 0.850 |
Why?
|
| Nerve Net | 1 | 2025 | 253 | 0.720 |
Why?
|
| Epileptic Syndromes | 1 | 2021 | 35 | 0.680 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 165 | 0.610 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 7 | 2023 | 284 | 0.600 |
Why?
|
| Long-Term Potentiation | 6 | 2015 | 103 | 0.550 |
Why?
|
| Mice | 30 | 2025 | 18160 | 0.530 |
Why?
|
| Neuronal Plasticity | 5 | 2018 | 283 | 0.460 |
Why?
|
| Animals | 33 | 2025 | 33660 | 0.430 |
Why?
|
| Parkinson Disease | 1 | 2021 | 720 | 0.430 |
Why?
|
| Neurons | 10 | 2025 | 1978 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 14 | 2025 | 4691 | 0.420 |
Why?
|
| Amygdala | 3 | 2003 | 73 | 0.400 |
Why?
|
| Neurogenesis | 3 | 2023 | 210 | 0.390 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2006 | 45 | 0.390 |
Why?
|
| Nicotine | 2 | 2010 | 115 | 0.360 |
Why?
|
| Avoidance Learning | 2 | 2021 | 53 | 0.340 |
Why?
|
| Behavior, Animal | 9 | 2020 | 475 | 0.320 |
Why?
|
| Conditioning, Classical | 3 | 2009 | 34 | 0.310 |
Why?
|
| Nicotinic Agonists | 1 | 2009 | 33 | 0.300 |
Why?
|
| Dopamine | 2 | 2014 | 244 | 0.300 |
Why?
|
| Gyrus Cinguli | 3 | 2005 | 131 | 0.290 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2010 | 124 | 0.280 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2021 | 69 | 0.270 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 265 | 0.260 |
Why?
|
| Seizures | 4 | 2022 | 876 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2025 | 53 | 0.220 |
Why?
|
| Mice, 129 Strain | 2 | 2021 | 96 | 0.210 |
Why?
|
| Gene Expression | 4 | 2016 | 1482 | 0.200 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2023 | 89 | 0.190 |
Why?
|
| Pain | 1 | 2005 | 431 | 0.180 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 570 | 0.180 |
Why?
|
| Auditory Pathways | 1 | 2001 | 20 | 0.180 |
Why?
|
| Electroencephalography | 3 | 2022 | 849 | 0.180 |
Why?
|
| Electrodes | 1 | 2021 | 81 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 324 | 0.170 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 140 | 0.170 |
Why?
|
| Male | 18 | 2025 | 64386 | 0.160 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 15 | 0.160 |
Why?
|
| Munc18 Proteins | 1 | 2020 | 21 | 0.160 |
Why?
|
| Chromatin | 1 | 2023 | 499 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 2330 | 0.160 |
Why?
|
| Polyadenylation | 1 | 2020 | 47 | 0.150 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 24 | 0.150 |
Why?
|
| Behavior | 1 | 2019 | 70 | 0.140 |
Why?
|
| Genes, Duplicate | 2 | 2015 | 16 | 0.140 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 4639 | 0.140 |
Why?
|
| Respiratory System | 1 | 2018 | 95 | 0.130 |
Why?
|
| Respiratory Center | 1 | 2017 | 9 | 0.130 |
Why?
|
| Substance P | 1 | 2017 | 31 | 0.130 |
Why?
|
| Motor Neurons | 1 | 2018 | 133 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2020 | 298 | 0.130 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 128 | 0.130 |
Why?
|
| Gene Dosage | 2 | 2015 | 435 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2018 | 236 | 0.120 |
Why?
|
| Sodium Channels | 1 | 2017 | 97 | 0.120 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2018 | 152 | 0.120 |
Why?
|
| Acoustic Stimulation | 4 | 2006 | 91 | 0.120 |
Why?
|
| Sodium | 1 | 2017 | 280 | 0.120 |
Why?
|
| GABAergic Neurons | 1 | 2016 | 67 | 0.120 |
Why?
|
| Spatial Learning | 1 | 2015 | 15 | 0.120 |
Why?
|
| Tauopathies | 1 | 2016 | 73 | 0.120 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 68 | 0.120 |
Why?
|
| Cognition Disorders | 2 | 2020 | 552 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2016 | 312 | 0.110 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 27 | 0.110 |
Why?
|
| Receptors, Adrenergic | 1 | 2014 | 15 | 0.110 |
Why?
|
| Perforant Pathway | 2 | 2014 | 9 | 0.110 |
Why?
|
| Aging | 2 | 2019 | 1238 | 0.110 |
Why?
|
| Extinction, Psychological | 2 | 2006 | 24 | 0.110 |
Why?
|
| Methylphenidate | 1 | 2014 | 58 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 378 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 534 | 0.100 |
Why?
|
| tau Proteins | 1 | 2016 | 258 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 131 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 782 | 0.090 |
Why?
|
| Female | 11 | 2023 | 70246 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 392 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2016 | 757 | 0.090 |
Why?
|
| Calcium | 1 | 2017 | 1009 | 0.090 |
Why?
|
| Mutation | 4 | 2023 | 6067 | 0.090 |
Why?
|
| Brain | 2 | 2023 | 3146 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1800 | 0.080 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 344 | 0.080 |
Why?
|
| Cognition | 1 | 2015 | 819 | 0.080 |
Why?
|
| Synaptic Potentials | 1 | 2009 | 14 | 0.080 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2009 | 29 | 0.080 |
Why?
|
| Mesencephalon | 1 | 2009 | 38 | 0.080 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3810 | 0.070 |
Why?
|
| Pyramidal Cells | 2 | 2022 | 151 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2885 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 270 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1076 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3404 | 0.060 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2006 | 12 | 0.060 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2006 | 25 | 0.060 |
Why?
|
| Synapses | 3 | 2005 | 428 | 0.060 |
Why?
|
| Phenotype | 1 | 2015 | 4456 | 0.060 |
Why?
|
| Hyperalgesia | 1 | 2005 | 26 | 0.060 |
Why?
|
| Muscimol | 1 | 2005 | 6 | 0.060 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2005 | 5 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2021 | 1025 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 1109 | 0.060 |
Why?
|
| Gene Duplication | 2 | 2016 | 358 | 0.050 |
Why?
|
| Random Allocation | 1 | 2005 | 409 | 0.050 |
Why?
|
| Electroporation | 1 | 2003 | 35 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 823 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 928 | 0.050 |
Why?
|
| Calmodulin | 1 | 2003 | 211 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2002 | 27 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 300 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2002 | 32 | 0.050 |
Why?
|
| Memory, Long-Term | 1 | 2022 | 28 | 0.040 |
Why?
|
| Geniculate Bodies | 1 | 2001 | 10 | 0.040 |
Why?
|
| Rats | 2 | 2005 | 3372 | 0.040 |
Why?
|
| Reaction Time | 1 | 2001 | 150 | 0.040 |
Why?
|
| Interneurons | 1 | 2022 | 144 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2022 | 190 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 808 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2020 | 71 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2013 | 101 | 0.040 |
Why?
|
| Hindlimb | 1 | 2020 | 72 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2014 | 234 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 130085 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2018 | 766 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 354 | 0.040 |
Why?
|
| Wakefulness | 1 | 2019 | 103 | 0.030 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2018 | 11 | 0.030 |
Why?
|
| Hypoglossal Nerve | 1 | 2018 | 11 | 0.030 |
Why?
|
| Inflammation | 1 | 2005 | 1478 | 0.030 |
Why?
|
| Homozygote | 1 | 2020 | 533 | 0.030 |
Why?
|
| Gliosis | 1 | 2018 | 31 | 0.030 |
Why?
|
| Protein Stability | 1 | 2018 | 164 | 0.030 |
Why?
|
| Protein Aggregates | 1 | 2018 | 37 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 87 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 721 | 0.030 |
Why?
|
| Ataxin-1 | 1 | 2018 | 166 | 0.030 |
Why?
|
| Periodicity | 1 | 2017 | 48 | 0.030 |
Why?
|
| Diaphragm | 1 | 2018 | 100 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 29 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 471 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2018 | 256 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 592 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 291 | 0.030 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2015 | 7 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2017 | 293 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 411 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2010 | 170 | 0.030 |
Why?
|
| Body Weight | 1 | 2020 | 985 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 375 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 373 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 800 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2001 | 726 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2107 | 0.030 |
Why?
|
| Theta Rhythm | 1 | 2014 | 22 | 0.030 |
Why?
|
| Integrases | 1 | 2015 | 157 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 63 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 645 | 0.030 |
Why?
|
| Mosaicism | 1 | 2016 | 247 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 1670 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 271 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 174 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 2729 | 0.030 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 11 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 29 | 0.030 |
Why?
|
| Lithium | 1 | 2013 | 66 | 0.030 |
Why?
|
| Hyperkinesis | 1 | 2013 | 26 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 97 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2018 | 920 | 0.020 |
Why?
|
| Anxiety | 1 | 2020 | 1005 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2013 | 140 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 1570 | 0.020 |
Why?
|
| Drosophila | 1 | 2016 | 721 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 712 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2322 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 269 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 313 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1604 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 44 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3713 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 877 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6765 | 0.020 |
Why?
|
| Nociceptors | 1 | 2005 | 14 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 2005 | 20 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 31011 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 258 | 0.010 |
Why?
|
| Microinjections | 1 | 2003 | 38 | 0.010 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2003 | 11 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 120 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 142 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 421 | 0.010 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2002 | 5 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 2002 | 8 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 358 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13269 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 243 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 344 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15005 | 0.010 |
Why?
|
| Motor Activity | 1 | 2003 | 488 | 0.010 |
Why?
|
| Piperidines | 1 | 2002 | 229 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1592 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2002 | 355 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20800 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 28314 | 0.010 |
Why?
|
| Child | 1 | 2018 | 26174 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6165 | 0.010 |
Why?
|